Sangamo Therapeutics
SGMO
SGMO
134 hedge funds and large institutions have $61.3M invested in Sangamo Therapeutics in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 33 increasing their positions, 49 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
134
Holders Change
-18
Holders Change %
-11.84%
% of All Funds
2.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
33
Reduced
49
Closed
26
Calls
$91K
Puts
$81K
Net Calls
+$10K
Net Calls Change
+$87K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VF
151
Virtu Financial
New York
| – | -$22K | -17,264 | Closed |
|
152
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$14.3K | -10,919 | Closed |
|
153
Point72 Asset Management
Stamford,
Connecticut
| – | -$13.3K | -10,252 | Closed |
|
|
GSC
154
Grey Street Capital
Chicago,
Illinois
| – | -$13K | -10,000 | Closed |
|
|
WIM
155
WealthPlan Investment Management
Omaha,
Nebraska
| – | -$520 | -400 | Closed |
|
|
FFA
156
Farther Finance Advisors
San Francisco,
California
| – | -$520 | -400 | Closed |
|
157
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$501 | -385 | Closed |
|
158
Nisa Investment Advisors
St. Louis,
Missouri
| – | -$116 | -89 | Closed |
|